These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28160086)

  • 1. Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.
    Knüppel E; Medinger M; Stehle G; Infanti L; Halter J; Burkhalter F; Mujagic E; Heim D; Passweg J
    Ann Hematol; 2017 Apr; 96(4):703-705. PubMed ID: 28160086
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell deplete versus T-cell replete haploidentical hematopoietic stem cell transplantation for sickle cell disease: where are we?
    Patel DA; Akinsete AM; Connelly JA; Kassim AA
    Expert Rev Hematol; 2019 Sep; 12(9):733-752. PubMed ID: 31291790
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential Risk Factors Associated With Graft Failure of Haploidentical Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Disease.
    Yu J; Black V; Lamba J; Horn B
    J Pediatr Hematol Oncol; 2021 May; 43(4):e583-e586. PubMed ID: 32604335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Leonard A; Tisdale J; Abraham A
    Br J Haematol; 2020 May; 189(3):408-423. PubMed ID: 32034776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?
    Oostenbrink LVE; Jol-van der Zijde CM; Jansen-Hoogendijk AM; Pool ES; van Halteren AGS; Moes DJAR; Bredius RGM; Mohseny AB; Smiers FJW; van Tol MJD; Schilham MW; Lankester AC
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):61-65. PubMed ID: 32202242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical bone marrow transplantation in a patient with sickle cell disease and acute myeloid leukemia.
    Chellapandian D; Nicholson CL
    Pediatr Transplant; 2020 Feb; 24(1):e13641. PubMed ID: 31880407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update.
    Patel DA; Akinsete AM; de la Fuente J; Kassim AA
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):91-97. PubMed ID: 32202252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
    Gomez-Arteaga A; Orfali N; Pasciolla M; Baptiste A; Guindine I; Hsu J; Lin J; Mayer SA; Phillips AA; Shore TB; Simonson PD; DiCarlo E; Yoon S; Muthukumar T; van Besien K
    Bone Marrow Transplant; 2023 Jul; 58(7):835-838. PubMed ID: 37045941
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploidentical Stem Cell Transplants in Children With Sickle Cell Disease: A Single Center Real-world Experience.
    Abdelkader S; Shah R; Crawford D; Baker A; Srinivasan A
    J Pediatr Hematol Oncol; 2024 Oct; 46(7):e556-e557. PubMed ID: 39185876
    [No Abstract]   [Full Text] [Related]  

  • 11. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review.
    Rashidi A; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Cashen AF; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1696-1701. PubMed ID: 27223108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease.
    Calore E; Marzollo A; Cananzi M; Pizzi M; Rugge M; Rossin S; Manara R; Tumino M; Basso G; Colombatti R; Sainati L
    Bone Marrow Transplant; 2018 May; 53(5):644-646. PubMed ID: 29335630
    [No Abstract]   [Full Text] [Related]  

  • 14. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
    Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
    Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for sickle cell disease: where do we go from here?
    Walters MC
    J Pediatr Hematol Oncol; 1999; 21(6):467-74. PubMed ID: 10598656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical stem cell transplantation-bone marrow vs peripheral blood.
    Gulbas Z
    Transfus Apher Sci; 2018 Apr; 57(2):168-170. PubMed ID: 29764770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in processing speed following haploidentical bone marrow transplant with posttransplant cytoxan in children and adolescents with sickle cell disease.
    Prussien KV; Patel DA; Wilkerson K; Armstrong B; Karnik L; de la Fuente J; Kassim AA
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28001. PubMed ID: 31595633
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic cell transplantation for hemoglobinopathies.
    Krishnamurti L; Bunn HF; Williams AM; Tolar J
    Curr Probl Pediatr Adolesc Health Care; 2008 Jan; 38(1):6-18. PubMed ID: 18068866
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor.
    Tanaka T; Ishida H; Shirakawa H; Amano H; Nishida H; Tanabe K
    Int J Urol; 2007 Nov; 14(11):1044-5. PubMed ID: 17956534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.